Novel Sequencing Tools to Play Important Role in Understanding Form of Papillary Thyroid Cancer: Research

According to data, next-generation sequencing analyses of the follicular variant of papillary thyroid carcinoma may elucidate the biological underpinnings and clinical behavior of an increasingly common disease. The data was presented at the 82nd ATA Annual Meeting in QuÃ©bec City, QuÃ©bec, Canada.

Papillary thyroid carcinoma, most common type of thyroid cancer, is the fastest growing cancer type in the United States and many other countries. The increase in incidence is largely attribute to a rise in the number of cases of follicular variant of papillary thyroid carcinoma. The follicular variant of papillary thyroid carcinoma is believed to behave in a clinical manner similar to usual or classical papillary cancer, but can be aggressive.RAS mutations are present in approximately 40% of follicular variant of papillary thyroid carcinomas, but little else is know about other mutations associated with the disease.

"A lack of understanding of molecular drivers of the follicular variant of papillary thyroid carcinoma greatly limits the ability to investigate reasons behind its increased incidence and hampers the development of more individualized management of patients," said Elizabeth Pearce, MD, of the Boston Medical Center and Program Co-Chair of the ATA annual meeting. "These new data suggest that novel genetic tools may shed new light in this important research area."

A team of researchers led by Lindsey Kelly, MD, at the University of Pittsburgh Medical Center, analyzed 501 samples of papillary thyroid carcinoma using a panel of next-generation sequencing tools. They found that 73% were positive for known mutations and 27% were negative for known mutations. The majority of the latter were determined to be follicular variant of papillary thyroid carcinoma. Further analyses of follicular variant of papillary thyroid carcinoma tumors revealed TPM3/NTRK1 fusion with a novel breakpoint, as well as several promising SNVs and SVs. These findings may allow better characterization of the biology and clinical behavior of follicular variant of papillary thyroid carcinoma.

Source: Newswise

For Papillary Thyroid Cancer Prognosis Older Age Marker May Be More Appropriate

A new study suggests that > 65 may be a more accurate age marker for prognosis.

Socioeconomic Status Linked to More Advanced Thyroid Cancer at Time of Diagnosis: Study

According to new data presented at the 82nd Annual Meeting of the American Thyroid Association, thyroid cancer among people with lower socioeconomic status is diagnosed at an advanced stage.

Some, but Not All Cases of Papillary Thyroid Cancer may Benefit from Radioactive Iodine Therapy

Research indicates radioactive iodine should only be used in the treatment of some patients with papillary thyroid cancer.

Hashimoto´s Thyroiditis

Hashimoto’s thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic hormone levothyroxine is an effective lifelong oral drug.

Hyperthyroidism

Hyperthyroidism is a condition in which the thyroid gland makes excessive thyroid hormone. Grave’s disease is the most common cause of hyperthyroidism.

Hypothyroidism

Symptoms of hypothyroidism are often general, unspecific changes in the body. Lethargy, weight gain, stiffness and cramping of muscles are some of the symptoms of hypothyroidism.

Hypothyroidism during Pregnancy

Hypothyroidism is a health condition where the thyroid gland produces less thyroid hormone. Hypothyroidism during pregnancy can seriously impact the health of the mother and baby in the womb.

Iodine Deficiency Disorder

To control IDD, the ‘National Goiter Control Program (NGCP)’ was launched which was later renamed as the ‘National Iodine Deficiency Disorder Control Program (NIDDCP)’.

Thyroid Cancer

“Shaped like a butterfly she sits within the neck,” that’s what an anonymous poet wrote about the thyroid gland but it can become cancerous and spread to other parts.